1,392 Shares in Astera Labs, Inc. $ALAB Purchased by Bank Julius Baer & Co. Ltd Zurich

Bank Julius Baer & Co. Ltd Zurich purchased a new stake in shares of Astera Labs, Inc. (NASDAQ:ALAB) in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 1,392 shares of the company’s stock, valued at approximately $126,000.

A number of other institutional investors and hedge funds have also bought and sold shares of the company. Straight Path Wealth Management grew its position in shares of Astera Labs by 1.5% during the 2nd quarter. Straight Path Wealth Management now owns 6,850 shares of the company’s stock worth $619,000 after buying an additional 100 shares in the last quarter. First Horizon Advisors Inc. lifted its stake in Astera Labs by 12.4% in the second quarter. First Horizon Advisors Inc. now owns 982 shares of the company’s stock worth $89,000 after acquiring an additional 108 shares during the period. Wealthcare Advisory Partners LLC grew its holdings in Astera Labs by 0.8% during the 2nd quarter. Wealthcare Advisory Partners LLC now owns 29,160 shares of the company’s stock worth $2,637,000 after acquiring an additional 221 shares in the last quarter. Main Management ETF Advisors LLC grew its holdings in Astera Labs by 1.7% during the 2nd quarter. Main Management ETF Advisors LLC now owns 14,660 shares of the company’s stock worth $1,326,000 after acquiring an additional 240 shares in the last quarter. Finally, Sound Income Strategies LLC increased its position in Astera Labs by 31.1% during the 2nd quarter. Sound Income Strategies LLC now owns 1,038 shares of the company’s stock valued at $94,000 after purchasing an additional 246 shares during the period. 60.47% of the stock is owned by institutional investors.

Astera Labs Stock Up 4.2%

ALAB stock opened at $147.75 on Tuesday. The stock has a market capitalization of $24.95 billion, a PE ratio of 133.11, a price-to-earnings-growth ratio of 2.64 and a beta of 1.38. Astera Labs, Inc. has a 52 week low of $47.13 and a 52 week high of $262.90. The firm has a 50 day moving average of $183.44 and a 200 day moving average of $147.33.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings results on Tuesday, November 4th. The company reported $0.49 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.39 by $0.10. Astera Labs had a net margin of 27.50% and a return on equity of 13.48%. The business had revenue of $230.58 million for the quarter, compared to analyst estimates of $206.42 million. During the same quarter in the prior year, the business posted $0.23 EPS. Astera Labs’s revenue for the quarter was up 103.9% compared to the same quarter last year. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. On average, equities research analysts expect that Astera Labs, Inc. will post 0.34 earnings per share for the current year.

Insider Transactions at Astera Labs

In other news, Director Jack R. Lazar sold 22,500 shares of the stock in a transaction dated Wednesday, August 27th. The stock was sold at an average price of $178.42, for a total value of $4,014,450.00. Following the transaction, the director directly owned 97,351 shares of the company’s stock, valued at approximately $17,369,365.42. This represents a 18.77% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Jitendra Mohan sold 90,459 shares of the firm’s stock in a transaction dated Monday, November 17th. The stock was sold at an average price of $144.69, for a total value of $13,088,512.71. Following the completion of the transaction, the chief executive officer owned 2,080,418 shares of the company’s stock, valued at approximately $301,015,680.42. The trade was a 4.17% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 619,436 shares of company stock worth $96,530,060 over the last 90 days. Insiders own 12.50% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on ALAB shares. BNP Paribas started coverage on shares of Astera Labs in a research report on Thursday. They issued an “outperform” rating for the company. Zacks Research lowered Astera Labs from a “strong-buy” rating to a “hold” rating in a report on Monday, October 6th. Susquehanna increased their target price on Astera Labs from $80.00 to $125.00 and gave the company a “neutral” rating in a research report on Thursday, August 7th. Raymond James Financial initiated coverage on Astera Labs in a research report on Friday. They issued a “hold” rating for the company. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Astera Labs in a research note on Wednesday, October 8th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and eight have given a Hold rating to the stock. According to MarketBeat, Astera Labs presently has a consensus rating of “Moderate Buy” and a consensus price target of $187.06.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.